NuvaRing is indicated for the prevention of pregnancy in women.
Cigarette smoking increases the risk of serious cardiovascular side effects from combination oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use combination hormonal contraceptives, including NuvaRing, should be strongly advised not to smoke.
Before prescribing NuvaRing, please read the Prescribing Information, including the Boxed Warning about the increased risk of serious cardiovascular side effects, especially in women who smoke.